New Europe Ventures

Silvair, Inc. is a technology company founded in 2013 and headquartered in Krakow, Poland. It specializes in providing software solutions for the Internet of Things, particularly in the smart lighting sector, primarily targeting markets in North America and Western Europe. The company develops Bluetooth-based interoperable wireless solutions designed for lighting manufacturers and intelligent building management systems. Silvair's product offerings include firmware for smart lighting components produced by third-party manufacturers, as well as tools for configuring, controlling, and managing lighting infrastructure. Additionally, the company provides analytics tools that utilize data collected from sensors integrated into lighting systems, enhancing the overall lighting experience for users.

Estimote Inc., established in 2012, specializes in developing sensor-based analytics platforms. Headquartered in New York with offices in San Francisco and Krakow, the company manufactures small wireless sensors called Estimote Beacons and Stickers, which utilize Bluetooth low energy to detect nearby smartphones and facilitate indoor location tracking. These sensors are primarily supplied to brick-and-mortar retail stores across the United States and Europe, enabling retailers to deliver targeted mobile advertising based on customers' in-store locations.

PiLab is a publically held software company based in Wroclaw, Poland. Their mission is to enable customers to unlock the enormous potential value that’s hidden within their myriad of data sets. The company develops advanced technology to power its products. To date the company has filed four patents. Currently PiLab products are available in Poland. In the future, the company intends to offer its products in the United States and other countries.

OncoArendi Therapeutics S.A. is a biopharmaceutical company based in Warsaw, Poland, focused on the discovery, development, and commercialization of therapeutics for neoplastic and inflammatory diseases. Established in 2012, the company is advancing several clinical candidates including OATD-01 for asthma, a CHIT1 inhibitor for idiopathic pulmonary fibrosis and sarcoidosis, and a therapy targeting the protein YKL-40 for glioblastoma multiforme and other cancers. OncoArendi emphasizes its capabilities in medicinal chemistry and preclinical biology, aiming to create innovative drug solutions while engaging in research partnerships to enhance its development efforts.

Estimote Inc., established in 2012, specializes in developing sensor-based analytics platforms. Headquartered in New York with offices in San Francisco and Krakow, the company manufactures small wireless sensors called Estimote Beacons and Stickers, which utilize Bluetooth low energy to detect nearby smartphones and facilitate indoor location tracking. These sensors are primarily supplied to brick-and-mortar retail stores across the United States and Europe, enabling retailers to deliver targeted mobile advertising based on customers' in-store locations.

Medicalgorithmics specializes in advanced cardiac diagnostics, focusing on remote ECG signal analysis. Its flagship product, PocketECG, is a non-invasive mobile solution for arrhythmia diagnosis. The company operates globally.